Intracellular staining and FACS demonstrated an increased percentage of CD8+ T cells secreting cytotoxic cytokines IFN-γ upon treatment (Fig. 4G), indicating enhanced induction of tumor antigen-specific CD8+ T cell responses. The gene discussed is CD8A; the disease is neoplasm.